Gain Therapeutics (GANX) - Aggregate Business Assets

Official company branding of gaintherapeutics.com (GANX)

The market price visualization of Gain Therapeutics, Inc. (GANX) total assets on GURU.Markets is 12.63, reflecting the dynamics of a company developing innovative small molecules via the SEE-Tx system to combat Gaucher and Parkinson's diseases. The strategy to minimize patent threats relies on a diversified drug portfolio; however, international conflicts and the sanctions regime are seriously hindering the cross-border exchange of biomaterials and clinical trials.

GANX (Gain Therapeutics, Inc.) Company Total Assets history from 07/04/2022 to 11/01/2026

Comprehensive metric breakdowns and analytics for Gain Therapeutics, Inc. (GANX)

- stock quotes and analyst forecast:
Share Price Gain Therapeutics Inc.|GANX - Consensus Target
- market capitalization indicators:
Market Value Gain Therapeutics, Inc.|GANX - Total Company Value
- balance sheet net asset value indicators:
Accounting Value of a Share Gain Therapeutics|GANX - Book Capitalization|Market-to-Book Ratio gaintherapeutics.com|GANX - Company Total Assets
- debt and liquidity details:
Total Debt to Capital Gain Therapeutics, Inc.|GANX - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio gaintherapeutics.com|GANX - Company Debts|Debt to Book Value Gain Therapeutics, Inc.|GANX - Company Long-Term Debts|Short-Term Debt Gain Therapeutics|Immediate Liquidity Ratio gaintherapeutics.com
- net income and valuation multiples indicators:
GANX - Net Income
Basic company analysis:GANX, Gain Therapeutics Inc.
Manufactured product of Gain Therapeutics Inc.

An assessment of resource quality at Gain Therapeutics, Inc. (GANX) allows investors to gauge capital management efficiency through the lens of return on assets. An analysis of consolidated assets, calculated inversely via ROA, reflects the total value of property, including high-tech infrastructure and diversified supply chains, confirming the company's financial resilience and operational stability.

Direct competitors

Total Business Assets HCA|Cumulative Company Assets THC|FMS (Fresenius Medical Care AG) - Aggregate Business Assets|Aggregate Company Assets Solventum Inc. (SOLV)|EHC (Encompass) - Aggregate Asset Value|Company Total Assets UHS (Universal Health Services, Inc.)|davita.com (DVA) - Company Assets|RadNet - Company Total Assets|OPCH - Company Total Assets|SGRY (Surgery Partners Corp) - Cumulative Company Assets|PINC: Aggregate Business Assets|Aggregate Company Assets National Vision Holdings|Cumulative Company Assets progyny.com (PGNY)|Company Total Assets ARDT|SEM - Company Assets|Aggregate Company Assets Apollo Medical Holdings ASTH|MD: Total Business Assets|USPH: Cumulative Company Assets|pennantgroup.com - Aggregate Business Assets|ORGO: Company Total Assets|Company Balance Sheet Assets Nutex Health Inc NUTX|AUNA (Auna Health) - Company Total Assets|Company Total Assets sbc-holdings.com|Company Total Assets EOLS|Company Total Asset Base chs.net|Aggregate Company Assets BeautyHealth SKIN|MDWD: Total Business Assets|BTMD: Cumulative Company Assets|Aggregate Asset Value JYNT (The Joint)|DCGO (DocGo Inc.) - Cumulative Company Assets|PIII: Aggregate Business Assets|EUDA (EUDA Health Holdings Limited) - Company Total Assets|BMGL: Aggregate Asset Value|Company Total Assets CLGN|CUPR - Company Assets|Aggregate Company Assets Concord Medical Services CCM|Aggregate Asset Value AMS|MEDIROM Healthcare Group - Company Total Assets|ALBT - Company Total Assets|DIH Holding US Inc. (DHAI) - Aggregate Company Assets|Total Asset Value of Company XAGE (Carmell Corp)|NIVF (NewGenIvf Group Limited) - Company Total Assets|Company Assets ATI Physical Therapy Corp ATIP|Cumulative Company Assets CMAX (CareMax)|Company Total Assets Kindly MD Inc (KDLY)|LogistiCare - Cumulative Company Assets|Aggregate Business Assets NVOS (Novo Integrated Sciences Corp)|SunLink Health Systems, Inc - Company Total Assets|Company Total Asset Base imacholdings.comm BACK